INTREPID

INTREPID project aims at developing a multi-sensor wearable system for the treatment of phobias and situational anxiety. INTREPID project actively contributes to the treatment of phobias in an unobtrusive, personalized and intelligent manner.

INTREPID will serve to empower Community citizens in the management of their individual health, to provide health care professionals and facilities with a reliable phobias treatment and decision support tool and to create new opportunities for the medical wearable device industry. INTREPID will build upon the well documented increasing demand for "healthy lifestyle" products and services on the consumer side and offer potentially significant returns for those who chose to invest in the project outcome.

The INTREPID project scientific objectives are:

  • To effectively exploit the synergy in the information acquired from the various biometric sensors and develop new and efficient data fusion techniques, which will significantly broaden machine perception and enhance awareness of the phobia's states.
  • To create an identification system of the physiological and phobia-based emotional state of a patient (phobia's state) that will be based on the association of the information coming from the various biometric sensors.
  • To create a decision-making system that will project the current patient's phobia state into the future and draw inferences about the actions that should be taken in order to keep the patient in the desired phobia's state.
  • To create a new centralised sensor management system that will use active and selective perception techniques in order to optimize the overall performance of the identification system and the tracking system.
  • To create a powerful, intelligent and innovative humancomputer interaction environment that will boost the research and work on affective wearable computing and machine emotional intelligence domain.

The INTREPID project technological objectives are:

  • To create an advanced tracking system that will optimally monitor the symptoms of phobias. The system will measure heart rate, perspiration rate, breath rate, muscle stiffness and if needed complementary modalities through a set of miniaturized wearable sensors that the patient wears during the treatment session.
  • To create a sophisticated environment in a commercial wearable computer that will consist of:
  • To create a professional site for psychologists and therapists that will assist them to design the next steps of the patient's therapy taking into account the individualized physiological and emotional state of each patient.

For further information, please visit:
http://www.intrepid-project.org

Project co-ordinator:
Manchester University (UK)

Partners:

  • UNIMAN (UK)
  • ESIEA (FR)
  • AURELIA MICRO (IT)
  • UoI (EL)
  • PALADION (EL)
  • Elyros (BE)
  • InFocus (UK)

Timetable: from 01/04 to 12/06

Total cost: € 3,228,334

EC funding: € 2,000,000

Instrument: STREP

Project Identifier: IST-2002-507464

Source: FP6 eHealth Portfolio of Projects

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...